Cargando…

An experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in Karachi, Sindh, Pakistan

BACKGROUND: Inactivated Polio Vaccine (IPV) campaign was conducted in February 2019 in Karachi where needle-free injectors were introduced for the administration of the fractional dose of IPV (fIPV) on a large scale. This study aimed to determine the impact of needle-free injectors on vaccination co...

Descripción completa

Detalles Bibliográficos
Autores principales: Bullo, Umar Farooq, Mehraj, Jaishri, Raza, Syed Musa, Rasool, Shumaila, Ansari, Noreen Naz, Shaikh, Ahmed Ali, Phul, Zamir Ali, Memon, Sohail Ahmed, Baloch, Rehan Iqbal, Baloch, Zahoor Ahmed, Chandio, Shoukat Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789602/
https://www.ncbi.nlm.nih.gov/pubmed/33407294
http://dx.doi.org/10.1186/s12889-020-10041-8
_version_ 1783633276109324288
author Bullo, Umar Farooq
Mehraj, Jaishri
Raza, Syed Musa
Rasool, Shumaila
Ansari, Noreen Naz
Shaikh, Ahmed Ali
Phul, Zamir Ali
Memon, Sohail Ahmed
Baloch, Rehan Iqbal
Baloch, Zahoor Ahmed
Chandio, Shoukat Ali
author_facet Bullo, Umar Farooq
Mehraj, Jaishri
Raza, Syed Musa
Rasool, Shumaila
Ansari, Noreen Naz
Shaikh, Ahmed Ali
Phul, Zamir Ali
Memon, Sohail Ahmed
Baloch, Rehan Iqbal
Baloch, Zahoor Ahmed
Chandio, Shoukat Ali
author_sort Bullo, Umar Farooq
collection PubMed
description BACKGROUND: Inactivated Polio Vaccine (IPV) campaign was conducted in February 2019 in Karachi where needle-free injectors were introduced for the administration of the fractional dose of IPV (fIPV) on a large scale. This study aimed to determine the impact of needle-free injectors on vaccination coverage. METHODS: In four towns of Karachi, fIPV was given using needle-free injectors “PharmaJet Tropis ID”. Whereas, in six towns full dose of IPV was administered to children of 4–59 months of age. Cluster surveys through rapid convenience assessment method were conducted after the completion of vaccination activity. RESULTS: A total of 33,815 households’ data was analyzed. Among these, 27,650 (82.8%) children were vaccinated. In fIPV areas, 85.3% of children were vaccinated compared to 79.5% in full dose IPV areas. A comparison of reasons for unvaccinated showed that 1.6% of parents do not give importance to vaccination in fIPV areas compared to 4.2% in full IPV areas (p-value < 0.0001). More children were not vaccinated due to fear of injection 1.8% in full IPV areas compared to 0.7% in fIPV areas (p-value < 0.0001). The source of campaign information shows that more frequent mobile miking 3.1% was observed in fIPV areas compared to 0.4% in full IPV areas (p-value < 0.0001). CONCLUSIONS: Our analysis supports the fractional dose of IPV in mass campaigns to achieve good vaccination coverage especially using needle-free injectors “PharmaJet Tropis ID” and vigorous social mobilization activities are expedient in accomplishing high coverage.
format Online
Article
Text
id pubmed-7789602
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77896022021-01-07 An experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in Karachi, Sindh, Pakistan Bullo, Umar Farooq Mehraj, Jaishri Raza, Syed Musa Rasool, Shumaila Ansari, Noreen Naz Shaikh, Ahmed Ali Phul, Zamir Ali Memon, Sohail Ahmed Baloch, Rehan Iqbal Baloch, Zahoor Ahmed Chandio, Shoukat Ali BMC Public Health Research Article BACKGROUND: Inactivated Polio Vaccine (IPV) campaign was conducted in February 2019 in Karachi where needle-free injectors were introduced for the administration of the fractional dose of IPV (fIPV) on a large scale. This study aimed to determine the impact of needle-free injectors on vaccination coverage. METHODS: In four towns of Karachi, fIPV was given using needle-free injectors “PharmaJet Tropis ID”. Whereas, in six towns full dose of IPV was administered to children of 4–59 months of age. Cluster surveys through rapid convenience assessment method were conducted after the completion of vaccination activity. RESULTS: A total of 33,815 households’ data was analyzed. Among these, 27,650 (82.8%) children were vaccinated. In fIPV areas, 85.3% of children were vaccinated compared to 79.5% in full dose IPV areas. A comparison of reasons for unvaccinated showed that 1.6% of parents do not give importance to vaccination in fIPV areas compared to 4.2% in full IPV areas (p-value < 0.0001). More children were not vaccinated due to fear of injection 1.8% in full IPV areas compared to 0.7% in fIPV areas (p-value < 0.0001). The source of campaign information shows that more frequent mobile miking 3.1% was observed in fIPV areas compared to 0.4% in full IPV areas (p-value < 0.0001). CONCLUSIONS: Our analysis supports the fractional dose of IPV in mass campaigns to achieve good vaccination coverage especially using needle-free injectors “PharmaJet Tropis ID” and vigorous social mobilization activities are expedient in accomplishing high coverage. BioMed Central 2021-01-06 /pmc/articles/PMC7789602/ /pubmed/33407294 http://dx.doi.org/10.1186/s12889-020-10041-8 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Bullo, Umar Farooq
Mehraj, Jaishri
Raza, Syed Musa
Rasool, Shumaila
Ansari, Noreen Naz
Shaikh, Ahmed Ali
Phul, Zamir Ali
Memon, Sohail Ahmed
Baloch, Rehan Iqbal
Baloch, Zahoor Ahmed
Chandio, Shoukat Ali
An experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in Karachi, Sindh, Pakistan
title An experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in Karachi, Sindh, Pakistan
title_full An experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in Karachi, Sindh, Pakistan
title_fullStr An experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in Karachi, Sindh, Pakistan
title_full_unstemmed An experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in Karachi, Sindh, Pakistan
title_short An experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in Karachi, Sindh, Pakistan
title_sort experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in karachi, sindh, pakistan
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789602/
https://www.ncbi.nlm.nih.gov/pubmed/33407294
http://dx.doi.org/10.1186/s12889-020-10041-8
work_keys_str_mv AT bulloumarfarooq anexperienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT mehrajjaishri anexperienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT razasyedmusa anexperienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT rasoolshumaila anexperienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT ansarinoreennaz anexperienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT shaikhahmedali anexperienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT phulzamirali anexperienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT memonsohailahmed anexperienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT balochrehaniqbal anexperienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT balochzahoorahmed anexperienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT chandioshoukatali anexperienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT bulloumarfarooq experienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT mehrajjaishri experienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT razasyedmusa experienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT rasoolshumaila experienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT ansarinoreennaz experienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT shaikhahmedali experienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT phulzamirali experienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT memonsohailahmed experienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT balochrehaniqbal experienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT balochzahoorahmed experienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan
AT chandioshoukatali experienceofmassadministrationoffractionaldoseinactivatedpoliovaccinethroughintradermalneedlefreeinjectorsinkarachisindhpakistan